Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Retrieved from National Library of Medicine-a
To assess the associations of semaglutide with recurrent AUD diagnosis (recurrent medical encounters for AUD diagnosis), the study population included 4254 patients who had active medical encounters for the diagnosis of obesity in 6/202112/2022, were for the first time (new-user design) prescribed semaglutide or non-GLP-1RA anti-obesity medications during 6/202112/2022 (index event), had a diagnosis of AUD on or before the index event and had a diagnosis of at least one of obesity-associated comorbidities on or before the index event
You will be directed to the health questionnaire
Zhang X, Chang E, Fu Y, Liu X, Xu J, Wu Y, Wang A, Dong X, Miao S
Each medication works in different ways: some lower appetite, others help patients feel full for longer, and some tackle the brain pathways that influence eating behavior
US$ 26.93
US$ 21.38
US$ 26.03
US$ 22.39
US$ 20.28
